Home›Stock Screener›Prevest Denpro

Prevest Denpro Share Price Today | Stock Price & Prevest Denpro Share Screener

PREVEST Medical Equipment

Track the current Prevest Denpro share price and stock price live with TickJournal's free stock screener. Check PREVEST 52-week performance for the annual price range and momentum. Use the Prevest Denpro stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Prevest Denpro opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹20 and net income of ₹5, with EBITDA of ₹8, an operating margin of 35.0% and a profit margin of 25.0%.

Prevest Denpro Market Cap ₹457.28 Cr.
PREVEST P/E Ratio (TTM) 22.79
Prevest Denpro P/B Ratio 3.91
EPS (TTM) ₹15.13
Dividend Yield 0.27%
Debt to Equity -
PREVEST 52 Week High -
Prevest Denpro 52 Week Low -
Operating Margin 35.00%
Profit Margin 25.00%
PREVEST Revenue (TTM) ₹20.00
EBITDA ₹8.00
Net Income ₹5.00
Total Assets ₹113.00
Total Equity ₹106.00

Prevest Denpro Share Price Chart

Track the current stock price of Prevest Denpro with an interactive chart. Analyse PREVEST share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Prevest Denpro stock quote in one place.

Prevest Denpro Company Profile - Fundamental Screener

Screen Prevest Denpro company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PREVEST shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Medical Equipment industry, and it trades under ISIN INE0GAO01018.

Company Details

Classification

Sector Healthcare
Industry Medical Equipment
Sub-Sector Medical Equipment
Segment E

Identifiers and Leadership

ISIN INE0GAO01018

Prevest Denpro Balance Sheet Screener

Screen PREVEST balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹113, up from ₹95 in 2024.

Latest statistics put total assets at ₹113 and shareholder funds at ₹106.

Item 2025 2024

Assets

Total Assets 113 95
Current Assets 86 68
Fixed Assets 27 27

Liabilities

Total Liabilities 0 0
Current Liabilities 1 1
Non-Current Liabilities 0 0

Shareholders' Equity

Total Equity 106 89
Share Capital 12 12
Reserves & Surplus 94 77

Prevest Denpro Income Statement Screener - Profit & Revenue Analysis

Screen Prevest Denpro income statement and profit fundamentals. Analyze PREVEST quarterly results. Prevest Denpro reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Mar, revenue was ₹20 and net profit was ₹5, equal to earnings per unit of ₹4.28, at an operating margin of 35%.

In that period expenses were ₹12, interest cost ₹0 and tax ₹2. The next period listed, 2025-Jun, shows revenue of ₹17 and net profit of ₹4.

Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 20 17 20 20 17 14 17 16 14 14 14
Expenses 12 10 12 13 10 9 11 10 8 9 9

Operating Costs and Margins

EBITDA 8 7 8 7 7 5 7 6 6 5 5
Operating Profit % 35.00% 34.00% 36.00% 31.00% 37.00% 34.00% 36.00% 35.00% 37.00% 33.00% 33.00%
Depreciation 1 1 1 1 1 1 1 1 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 7 6 7 6 6 5 6 6 5 5 5
Tax 2 2 2 2 2 1 2 1 1 1 1
Net Profit 5 4 6 5 5 4 5 5 4 4 4
EPS 4.28 3.67 4.62 3.93 3.98 3.06 4.01 3.77 3.40 3.04 3.03

Prevest Denpro Cash Flow Screener - Liquidity Fundamentals

Screen PREVEST cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹15, and net cash flow was an inflow of ₹12.

Over the same period, investing activities used ₹1 and financing activities used ₹1.

Item 2025-March 2024-March

Cash from Operations and Investing

Operating Activities 15 12
Investing Activities -1 -2

Financing and Net Cash

Financing Activities -1 0
Net Cash Flow 12 10

Prevest Denpro Shareholding Pattern Screener

See Prevest Denpro shareholding pattern with promoter, FII, and DII holdings. Check Prevest Denpro promoter holding and ownership changes for PREVEST on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Mar, promoters held 73.60%, foreign institutions 0.63%, domestic institutions 1.28% and the public 19.54%, spread across 1,887 shareholders.

The shareholder count was 1,887 in 2025-Mar, compared with 1,928 in 2025-Jun.

Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec

Promoter Holding

Promoter Holding 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60%

Institutional Investors

FII Holding 0.63% 0.63% 0.63% 0.65% 0.52% 1.11% 0.63% 0.63%
DII Holding 1.28% 1.22% 0.75% 0.77% 0.68% 0.68% 0.68% 0.71%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 19.54% 19.68% 19.97% 19.78% 19.43% 18.61% 20.35% 20.04%
Other Holding 4.95% 4.86% 5.05% 5.20% 5.76% 5.99% 4.73% 5.01%
Shareholder Count 1,887 1,928 1,888 1,957 1,991 1,896 1,822 1,832

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Prevest Denpro. Prevest Denpro dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹1.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹1.00 and ₹1.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹1.00 0.27%
2024-March ₹1.00 0.23%
2023-March ₹1.00 0.28%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Prevest Denpro Stock Index Membership - Nifty & Sensex

See which indices include Prevest Denpro stock. Check PREVEST index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Prevest Denpro is not part of any tracked indices.
Only major market indices are tracked in our system.

Prevest Denpro Market Events Screener - Corporate Actions

Get Prevest Denpro corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Prevest Denpro stock events that may affect PREVEST share price, along with derivatives, futures and options activity and sector gainers.

11 corporate actions are listed, the most recent entry being Annual General Meeting dated .

It is followed by Annual General Meeting dated and Dividend dated .

Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -1.51%
Annual General Meeting NA 10.24%
Dividend ₹ 1.00 /share 5.47%
2026-02-14 2026-02-14 Quarterly Result Announcement NA -1.01%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -6.66%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 3.89%
2025-05-27 2025-05-27 Quarterly Result Announcement NA 1.10%
2025-02-01 2025-02-01 Quarterly Result Announcement NA -2.03%
2024-11-11 2024-11-11 Quarterly Result Announcement NA 3.46%
2024-08-30 2024-08-30 Dividend ₹ 1.00 /share -8.05%
2023-08-23 2023-08-23 Dividend ₹ 1.00 /share -18.81%

Prevest Denpro Competitors Screener - Peer Stocks Comparison

Screen PREVEST competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Poly Medicure 12,578 36.04 1,759 22.62% 339 39.22
Tarsons Products 982 47.68 408 32.64% 30 39.87
Laxmi Dental 955 42.19 242 24.12% 25 37.86
Osel Devices 922 45.05 187 40.62% 20 55.37
Vasa Denticity 690 52.53 251 45.01% 17 32.34
Fabtech Technologies 647 20.32 336 45.66% 47 45.32
Prevest Denpro 457 22.79 67 13.15% 18 29.92
Aprameya Engineering 415 25.44 136 107.77% 16 45.60
Hemant Surgical Industries 359 43.31 112 % 8 49.87
Nureca 238 21.60 122 19.24% 1 29.81

Prevest Denpro Company Announcements - News & Reports Screener

Screen PREVEST latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated February 14, 2026.

The next most recent announcements are dated February 14, 2026 and February 14, 2026.

Date Update Actions
2026-02-14 Disclosure Under Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-02-14 Outcome Of The Board Meeting Held Today I.E. February 14 2026 -
2026-02-14 Board Meeting Outcome for Unaudited Financial Results Of The Company For Quarter Ended December 31 2025. -
2026-02-09 Board Meeting Intimation for Consider And Approve Unaudited Financials Results Of The Company -
2026-01-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-31 Closure of Trading Window -
2025-11-24 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2025-11-21 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2025-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2025-11-17 Intimation Regarding Postponement Of Analyst / Institutional Investor Earnings Call Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2025-11-14 Announcement under Regulation 30 (LODR)-Investor Presentation -
2025-11-14 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2025-11-12 Unaudited Financial Results Of The Company For The Quarter Ended September 30 2025 -
2025-11-12 Board Meeting Outcome for Held On Wednesday November 12 2025 -
2025-11-06 Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For Quarter And Half Year Ended On September 30 2025. -
2025-10-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-09-29 Closure of Trading Window -
2025-09-11 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-09-10 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-08-15 Announcement under Regulation 30 (LODR)-Press Release / Media Release -

Frequently Asked Questions

How is the company valued right now?

The P/E ratio is 22.79 and the P/B ratio is 3.91, with earnings per unit of ₹15.13. Market capitalisation stands at ₹457.28 Cr and the dividend yield is 0.27%. The company operates in the Healthcare sector, in the Medical Equipment industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 6, 2026. This page covers 2 balance sheet periods, 11 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.